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Summary 
The extravasation ofleukocytes from the blood into tissues occurs as a multistep process: an ini- 
tial transient interaction ("rolling"), generally thought to be mediated by the selectin family of 
adhesion molecules, followed by firm adhesion, usually mediated by integrins. Using a parallel 
plate flow chamber designed to approximate physiologic flow in postcapiUary venules, we have 
characterized a rolling interaction between lymphoid cells and adherent primary and cultured 
endothelial cells that is not selectin mediated. Studies using blocking monoclonal antibodies in- 
dicate that this novel interaction is mediated by CD44. Abrogation of the rolling interaction 
could he specifically achieved using both soluble hyaluronate (HA) and treatment of the adher- 
ent cells with HA-reactive substances, indicating that HA is the ligand supporting this rolling 
interaction. Some B  and T  cell hnes, as well as normal lymphocytes, either constitutively ex- 
hibit rolling or can be induced to do so by phorbol ester or in vivo antigen activation. These 
studies indicate that CD44 and its principal ligand hyaluronate represent another receptor/car- 
bohydrate hgand pair mediating a novel activation-dependent pathway of lymphocyte/endo- 
thelial cell adhesion, 
T 
he venules in which circulating leukocytes must  en- 
gage the vessel wall are subject to high shear stresses, 
resulting in the requirement for specialized adhesion mech- 
anisms to ensure that arrest and extravasation ofleukocytes can 
occur appropriately. It has become clear that the specificity 
and regulation of adhesion results from various types of ad- 
hesion  receptors acting in  sequential  fashion.  The major 
steps  of adhesion,  described primarily for neutrophils, have 
included a primary event, during which leukocytes are en- 
gaged by the vessel wall and then retarded by a repeated 
transient interaction, followed by release. This results in a 
stuttered traversing of the  length  of the  vessel  known  as 
"rolling," which is followed by a secondary firm adhesion 
of the  rolling cells  and  subsequent  transmigration  (1,  2). 
Primary adhesion has  been attributed in different systems 
to the interaction between the lectin domain of  members of 
the selectin family and their carbohydrate hgands on endo- 
thelial cells (EC) l, whereas secondary (firm) adhesion is due to 
heterodimeric [32 integrins interacting with their EC ligands, 
1Abbreviations used in this paper: bPG, bovine proteoglycan;  CS-A, chon- 
droitin sulfate A; DCF, Ca2+Mg2+-free HBSS; EC, endothelial cell; F1- 
HA, Fluorescein-conjugated  HA; GoeRIg, goat anti-rat Ig; HA, hyalur- 
onate; HS, heparin sulfate; ICAM, intraceUular  adhesion molecule. 
members of  the immunoglobuhn gene superfamily, primar- 
ily intracellular adhesion molecule (ICAM)  1 and ICAM-2 
(for review see reference 3).  The primary (rolling)  interac- 
tion does not require activation of the selectin molecule and 
is transient, releasable,  and immediately repeatable, whereas 
the secondary (firm)  adhesion  event requires  activation of 
integrin molecules and is not readily reversible. 
Although much of this multistep model of adhesion under 
shear forces was established based on neutrophil-EC interac- 
tions, it has been less clear whether these rules are equally 
applicable to the even more complex extravasation physiol- 
ogy oflymphocytes. Lymphocytes have been shown to roll 
both in in vivo and in vitro shear stress flow assays, and in 
many instances this primary adhesion is selectin dependent 
(4-7). Furthermore, [32, as well as other integrins not char- 
acterized in neutrophils  (i.e., ci4131 and r  participate 
in secondary lymphocyte adhesion (8-10).  However, data 
pointing toward additional molecular complexity of lym- 
phocyte extravasation mechanisms have recently emerged. 
For example, 0e4131 and ci4137 integrins  on lymphocytes have 
been shown to mediate primary as well as secondary inter- 
actions (11), and primary adhesion of  human T cells has been 
shown to use as yet uncharacterized molecules (7). 
Because mechanisms  of lymphocyte trafficking must  ac- 
commodate the additional complexities of a myriad of dis- 
1119  J. Exp. Med. ￿9  The Rockefeller University Press ￿9 0022-1007/96/03/1119/12  $2.00 
Volume 183  March 1996 1119-1130 tinct, sometimes tissue-specific, homing behaviors, it would 
not be surprising if other ligand pairs participated  in lym- 
phocyte interactions with endothelium. Here,  using a par- 
attel plate flow chamber designed to approximate postcapil- 
lary physiologic flow, we have characterized a novel rolling 
interaction  between  lymphoid cells  and  adherent  cultured 
EC  which  is  not  selectin  or o~4-integrin  mediated.  Our 
studies indicate  that this novel interaction has as its basis a 
distinct protein-carbohydrate ligand interaction, namely, the 
interaction between the proteoglycan core and cartilage link 
protein family member CD44 and its principal ligand, hy- 
aluronate (HA). Phorbol ester activation, known to induce 
HA  binding,  also  induces  rolling  behavior  in  several 
CD44-bearing  lymphoid  cell  lines  as  well  as  in  normal 
lymphocytes, which do not otherwise exhibit this activity, 
indicating CD44 may function in lymphocyte extravasation 
as  an  activation-dependent  primary  adhesion  molecule. 
These results  further our understanding of  functional roles for 
CD44 and its interaction with  HA, help  clarify the previ- 
ously proposed but poorly defined role  of CD44 in lym- 
phocyte homing, and suggest that CD44 might selectively 
participate in the well-described enhanced homing of acti- 
vated lymphocytes to sites  of inflammation. 
Materials  and Methods 
Chemkab and Reagents.  PMA,  rooster  comb hyaluronate  (HA), 
chondroitin sulfate A (CS-A), heparin sulfate (HS)~ and neuramini- 
dase were purchased from Sigma Chemical Co. (St. Louis,  MO) 
and streptococcal hyaluronidase  was purchased from ICN (Irvine, 
CA). Hyaluronidase and neuraminidase  were used for 1 h at 37~ 
at final concentrations of 20 TR.U/ml and 1 U/ml, respectively. 
Ionomycin was purchased  from Calbiochem Corp. (La Jolla, CA). 
Fluorescein-conjugated HA (F1-HA) was the generous gi~ of J. 
Lesley  (Sulk Institute,  La Jolla,  CA).  Biotinylated bovine  pro- 
teoglycan (bPG)  extracted  from bovine nasal cartilage was kindly 
provided  by  C.  Underhill  (Georgetown  University  School  of 
Medicine, Washington, DC). 
Cell Culture and Antibodies.  The murine LN endothelial lines 
SVEC4-10 (provided by K.A. O'Connell, Johns Hopkins Uni- 
versity School of Medicine, Baltimore, MD) (12) and TME-3H3 
(provided by A. Hamann, Department of Immunology, Medizin- 
ischen Klinic, Hamburg, Germany)  (13) are SV40-wansformed lines 
derived from LN stroma.  The murine T  cell line SAKRTLS12 
was the gift of P~ Kincade (OMR.F, Oklahoma City, OK) and J. 
Lesley. Murine T cell lines and B cell hybridomas were maintained 
in DMEM or R_PMI 1640 with high glucose, 15% FCS plus pyru- 
vate, and glutamine.  Activation ofT cell lines and normal mouse 
lymphocytes was accomplished by adding 1 ng/ml PMA plus 500 
ng/ml ionomycin to the tissue  culture medium and incubating 
for 18-24 h at 37~ 
Primary LN EC cultures  were made by pooling cervical  and 
axial  nodes  from three  animals,  as  described  (14,  15). Organs 
were minced, rinsed  to remove lymphocytes, treated with colla- 
genase for 30 rain at 37~  and plated on 35-turn culture dishes in 
supplemented  IMDM  (20% FCS).  After confluence, cells were 
used directly or after a single passage to fresh plates. FACS  |  anal- 
ysis indicated that >99% of the population stained positive for the 
known endothelial  markers MECA-32, CD31, and endoglin, and 
negative for the macrophage marker MAC-1. Human umbilical 
vein EC were prepared and kindly provided by N.  Oppenhei- 
mer-Marks  (University of Texas  Southwestern  Medical  Center 
[UTSWMCI). 
The following mAhs were used in these  studies:  anti-CD44 
antibodies  KM201, KM81  (16), IM7 (17) (American Type Cul- 
ture Collection, KockviUe, MD), and IRAWB14, provided by J, 
Lesley (18); anti-P-selectin 10A10 and anti-E-selectin 9A9, the 
of B.A.  Wolitzky (Hoffmann-LaR.oche Inc.,  Nutley,  NJ);  anti- 
VCAM antibodies MK1.9.2 and MK2.7.1, the anti-ICAM-1 anti- 
body YN-1, provided by P. Thorpe (UTSWMC); anti-ICAM-2 
3C4, provided by A. Takashima  (UTSWMC); anti--a4  integrin 
K1.2,  anti-MAC-1  M1/70,  anti-peripheral  node  addressin 
MECA  79,  and  anti-mucosal  addressin  MECA367  (19);  anti- 
endoglin and MECA32 (20), provided by E. Butcher (Stanford 
University,  Stanford,  CA);  anti-CD31  (21)  and  anti-sLe  ~ 
HECA452;  anti-LFA-1  132  M17/4  (PharMingen,  San  Diego, 
CA),  anti-Thyl.1  (Bioproducts  for Science,  Inc.,  Indianapolis, 
IN);  anti-CD45R,  a  MB23G  (American  Type  Culture  Collec- 
tion).  FITC- and PE-conjugated goat anti-rat  immunoglobulin 
(G~xl~Ig) were  purchased  from Cappel  Laboratories,  Cochran- 
ville,  PA),  and  streptavidin-PE  was  obtained  from  CALTAG 
Laboratories,  South San Francisco~ CA). 
In Vivo Aaivation  of  Murine LN Cells.  8-10-wk-old  C57B1/6 
mice were injected in the hind footpad and at the base of the tail 
with 25 I~1 of CFA emulsified  1:1 with 25 ~1 of PBS. Two addi- 
tional injections in the base of the tail were given at weekly inter- 
vals, and draining inguinal  LN as well as distal control nodes were 
harvested 3 d after the last injection. 
FACS  |  Analysis.  5 ￿  l0  s ceils were stained with primary an- 
tibody, F1-HA, or bPG--biotin in 100 ~1 PBS/5% FCS for 20 min 
on ice and  then  washed  with  1  ml  of PBS/5%  FCS.  Fluoro- 
chrome-labeled secondary antibody or streptavidin  was added for 
20 n'fin, and cells were again washed before analysis. Data were 
collected  on  a  FACScan  |  analytical  instrument  (Becton  Dick- 
inson, San Jose, CA) and analyzed using Lysis II (Becton Dickin- 
son) software. 
Adhesion Assay under Flow Conditions.  Physiological flow condi- 
tions were produced using a parallel plate flow chamber as previ- 
ously described (22). Briefly, flow occurs over a 35-mm tissue cul- 
ture dish (Coming Inc., Coming, NY) containing either an adherent 
cell monolayer or a coating ofsubstrate. The culture dish and a plexi- 
glass chamber are held 1.27  ￿  10 -2 cm apart by a silicon  gasket 
cut to form two flow chambers,  each 0.6 cm wide.  The wall shear 
stress for this geometry can be calculated as previously described (22). 
Unless otherwise noted, experiments were carried out at a wall shear 
stress of 2.0 dynes/cm  2. 
SVEC4-10, TME-3H3, and primary LN EC were plated and 
used at confluence. Soluble HA and CS-A were plated at 2.5 mg/ 
ml in PBS, 1 ml/plate, and incubated  overnight at 4~  on a rocking 
platform, and then blocked with 1 ml FCS at 4~  for 1 h before 
use.  After equilibration  of flow with  medium alone,  lymphoid 
cells were resuspended at a concentration of 3 ￿  106 cells/mi in 
RPMI 1640 equilibrated  to 37~  and pulled continuously across 
the flow chambers.  For Ca2+Mg2+-free  experiments,  lymphoid 
cells  and  endothelial  monolayers were  washed  three  times  in 
I-~BSS without CaZ+Mg  2+ (DCF), and lymphoid cells were fur- 
ther incubated in DCF for 30 rain, washed,  and applied to the as- 
say. For blocking studies, antibodies  were either added at saturat- 
ing concentrations to the cell suspension  before flow or added to 
the inlet solution once the cells had already begun to perfuse into 
the  chamber.  HA-blocking studies  were  performed  by adding 
soluble HA to the cell suspension before flow. Interaction of  lym- 
phoid cells with the substrate was monitored by the use of an in- 
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Garden City, NY) connected to a video camera and recorder. 
For quantitation of roiling,  ceils were introduced continuously 
for 4 min, and rolling was allowed to equilibrate  before recording 
was begun. Each experiment was recorded for 5-10 rain, with fields 
of view being changed every minute. Using the video recording, 
the number of cells rolling in a given field  (0.48 nam~ for each 
minute time increment was counted. The cell counts for each field 
per minute were summed, and an average number of cells per 
field  per minute  was  calculated  based on the  number of fields 
viewed and expressed as ceUs/mm  z per minute. Cell-rolling veloc- 
ities were obtained by determining the amount of time necessary 
for a given cell to move a calibrated  distance. For average velocity 
and velocity distributions,  ,'~  interacting cells from three sepa- 
rate experiments  were assessed. In settling  experiments,  flow was 
stopped,  and cells were allowed to settle for 4 rain before reiniti- 
ating flow and determining the fraction of cells interacting. 
Results 
Pn'mary Adhesion (Rolling) of  a Murine T Cell l.a'ne, BW5147, 
on a Murine LN EC Line.  Using a parallel plate flow cham- 
ber  (22),  a  murine  clonal  T  cell line,  BW5147,  was per- 
fused over confluent monolayers of the SV40-transformed 
LN endothelial line SVEC4-10 at a wall shear stress of 2.0 
dynes/cm  2. This shear stress is considered to be within the 
physiologic range  found in venules  and some large blood 
vessels  (23-25),  and has been shown to discriminate selec- 
tin-  and  integrin-mediated  interactions  (7).  Under  these 
conditions, the interaction observed was predominantly that 
of rolling (Fig. 1 A), which was manifested by ~97% of the 
interacting cells.  Less than 3% of the interacting cells were 
observed to firmly adhere,  and these also showed a rolling 
interaction preceding arrest.  If flow was stopped and then 
restarted  after  allowing  cells  to  settle  on  the  endothelial 
monolayer,  essentially the  entire population began to roll, 
indicating  that these  clonal lymphoid cells were homoge- 
neous with respect to the capacity to engage in the rolling 
interaction.  In addition,  cells interacted  with the EC sub- 
strate over a range of wall shear stresses  (Fig. 1 A). Through- 
out this  range,  95-100%  of the interacting cells  exhibited 
rolling (Fig. 1 A), suggesting that the rolling interaction is a 
property intrinsic to this lymphoid cell on the substrate rather 
than  to a  particular condition  of flow. At 2.0  dynes/cm  2, 
the lymphoid cells were observed to roll at an average ve- 
locity of 12.9  +  6.4 (SD) ~m/s. The distribution of veloc- 
ities within a population of'~200 cells from three separate 
experiments was determined and is shown in Fig. 1 B; 79% 
of the interacting cells rolled at velocities between 5.0 and 
20.0  ~m/s.  These velocities and shear stress responses are 
comparable to those observed between  the selectin family 
of adhesion  molecules  and  their  endothelial  carbohydrate 
ligands (2, 22, 24, 26-28). Furthermore, the level of tether- 
ing (defined as the number of cells undergoing initial con- 
tact in the first 20 s after commencing flow [29]) was deter- 
mined  to  be  "-~50%  higher  over  a  range  of comparable 
shear  stresses  than  that  reported  with  the  most  efficient 
lymphoid cells in other systems (29, 30) (data not shown). 
Independence of B W 514 7 / E C  Primary Adhesion from Selec- 
tin--Ia'gand Interactions.  Because  the  phenomenon  of leuko- 
cyte  rolling  has  been  primarily  attributed  to  the  selectin 
family of adhesion molecules, both BW5147 and SVEC4-10 
were analyzed for selectin expression.  Neither cell line ex- 
presses  detectable  L-selectin,  P-selectin,  or  E-selectin,  as 
measured by cell surface staining (data not shown). In addi- 
tion,  Northern blot analysis for RNA  shows no L-selectin 
transcripts  in BW5147  (data  not shown).  The  cells  lacked 
detectable  MAC-l,  LFA-1  J32, or et4 integrins,  but dem- 
onstrated  high  levels  of surface  CD44  (data  not  shown). 
Therefore, CD44 appears to be the major known adhesion 
molecule borne by this BW cell line. By additional FACS  | 
analysis (data not shown),  SVEC4-10 appears to be devoid 
of the EC adhesion molecules VCAM-1 (the counterligand 
for c~4 integrins),  ICAM-1  and -2  (the known endothelial 
~2  integrin  ligands),  peripheral  node  addressin(s)  (a  set  of 
high-affinity L-selectin ligands expressed by high endothelial 
venules),  and the mucosal addressin MAdCAM-1  (the pri- 
mary ligand for ot4J37-integrin).  However, CD44 was also 
expressed on this endothelial line. 
Selectin-ligand  interactions  are  known to be  Ca  2+  de- 
pendent  by virtue  of the  Ca2+-dependent  NH2-terminal 
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Figure 1.  Characteristics  of the rolling inter- 
action of BW5147 on SVEC4-10 monolayers. 
(A)  Rolling  interaction  of  BW5147 with 
SVEC4-10 at varying  wall shear stress. BW5147 
cells were applied to feed solution already equil- 
ibrated under flow at an initial wall shear stress 
of 4.0 dynes/cm  2 and perfused over a mono- 
layer ofSVEC4-10 EC in the parallel plate flow 
assay. The flow rate of  the feed solution was in- 
crementaUy adjusted by decreasing the  outlet 
pump speed to effect altered wall shear stress, as 
previously reported (2). The number of cells/ 
mm  2 per minute rolling across the monolayer 
(0) was determined for each wall shear stress af- 
ter equilibration. In addition, total numbers of 
interacting cells (rolling plus adherent) at each 
wall shear stress were counted, and  the  total 
number of adherent cells was determined. Results of total adherent cells are from a representative experiment (IZl). (B) Velocity distribution of rolling 
BW5147 cells at a wall shear stress of  2.0 dynes/cm  2. Rolling was analyzed as described in Materials and Methods, and the frequency ofceUs within each 
velocity range was calculated as a percentage of  the total number of  cells evaluated (~200). 
1121  DeGrendele et al. lectin domains ofselectins (31, 32). Performing the flow as- 
say  in  Ca2+MgZ+-free  (DCF)  medium  (Fig.  2  A)  or  in 
EDTA (0.25 raM) had no effect on BW5147 roUing. Like- 
wise, neuraminidase treatment of the BW5147 cells, known 
to abrogate selectin-mediated interactions with their carbo- 
hydrate ligands, showed essentially no effect on the rolling 
interaction  (Fig.  2  A).  In  addition,  anti-sLe  x  antibodies 
showed no staining of the endothelial monolayer (data not 
shown).  Lastly,  EL4  hi,  a  variant  of the  T  cell  line  EL4, 
which  has  been  selected for  high  levels of expression  of 
L-selectin, showed no ability to roll or interact in this sys- 
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Figure 2.  Inhibition of rolling of BW5147 cells on SVEC4-10 mono- 
layers in the parallel plate flow assay. (A) P~eagents used for treatment of 
the lymphoid (upper) or endothelial (lower)  cells are indicated. Performing 
the  assay in  Ca2+Mga+-free HBSS (DCF  medium)  and  treatment  of 
BW5147 with hyalurorfidase  or neuraminidase had no effect on the roll- 
ing interaction. Antibody treatments were performed by incubation of ei- 
ther BW5147 cells or SVEC4-10 cells with anti-CD44 or control mAb 
and  washing before  addition  of BW5147  cells to  the  feed solution. 
t3W5147 cells were treated with anti-CD44 mAbs KM201, KM81, IM7, 
and IRAWB14, or with control antibodies Thyl.1 or H-2K  k. SVEC4-10 
cells were treated with anti-CD44 antibodies or an irrelevant isotype con- 
trol antibody M1/70  (anti-MAC-I) by 30-rain incubation before assay 
with no effect on rolling. However, treatment of SVEC4-10 with bPG 
inhibited rolling. In all cases, excess  reagent was removed by washing cells 
before the flow assay. (B) Antibody to CD44 or Thyl.1 was added to the 
feed solution after achieving steady-state rolling of  BW5147. Rolling cells 
were monitored for up to 7 rain for visible effects by antibody and were 
seen to release from the surface after the addition of IM7, whereas anti- 
Thyl.1 had no significant  effect. 
tem (Table 1). The cumulative data indicate that this inter- 
action is not selectin mediated. 
Inhibition  of BW5147-EC  Rolling Interaction by Treatment 
with CD44-specific  mAbs.  To determine the role of CD44 
in this interaction, the anti-CD44 Abs KM201, KM81, and 
IM7  were  tested for their effects  on  BW5147  rolling. As 
seen in Fig. 2 A, all of these antibodies completely and spe- 
cifically inhibited the BW5147-SVEC4-10  rolling interac- 
tion when BW5147 cells were preincubated with antibody, 
washed, and then applied to the assay. A  fourth anti-CD44 
antibody (IRAWB14), which does not inhibit CD44-HA 
interactions (18), did not inhibit rolling. Two control anti- 
bodies, anti-Thyl.1  and anti-H-2K  k, which recognize cell 
surface markers expressed at high levels on BW5147,  also 
showed no significant effect on rolling. Since, in continu- 
ous flow, both  initial contact  (tethering)  as well as subse- 
quent rolling are required to observe the interaction, it was 
of interest  to  assess  the  effect  of anti-CD44  antibody  on 
rolling in isolation. Therefore, flow was initiated and anti- 
body was introduced after cell rolling was in progress. All 
of the  cells in  the  field were  followed to  the  end  of the 
chamber over a 7-rain period after the introduction of anti- 
body. It can be seen in Fig. 2  B  that anti-CD44 mAb, but 
not anti-Thyl. 1, resulted in the loss of cells interacting with 
the monolayer surface over time,  although initial cell-cell 
contact (tethering) had already been established. When flow 
was stopped in the presence of blocking antibody and cells 
were  allowed to settle, the reinitiation of flow resulted in 
the immediate "washing away" of the setded cells, without 
any  indication  of even  transient  interaction.  Taken  to- 
gether,  these  experiments suggest that both  initial contact 
as well as subsequent rolling is mediated by CD44. 
Because SVEC4-10  also expresses CD44,  it was impor- 
tant to determine whether endothelial CD44 contributed to 
this interaction as well. Saturating levels of anti-CD44 anti- 
bodies were added to the endothelial monolayers, allowed 
to incubate for 15 rain, and rimed to remove excess antibody 
immediately before initiation of flow of BW5147.  Primary 
adhesion was not affected by pretreatment of SVEC4-10 with 
any  of the  blocking  antibodies  KM201,  KM81,  or  IM7 
(Fig. 2 A), and FACS  |  analysis after the assay showed anti- 
body still bound to the EC (data not shown).  These results 
suggest that it is the  CD44  on  the  lymphoid cell that  has 
the primary role in this adhesive interaction. In further sup- 
port  of this,  whereas  both  BW5147  and  SVEC4-10  are 
CD44 +, only BW5147 binds HA (data not shown). 
Mediation  of CD44-dependent Rolling  Occurs via the CD44 
Ligand Hyaluronan.  Because HA is one of the best-studied 
ligands for CD44,  and HA has been reported previously to 
be expressed on small vessel vascular endothelium (15), we 
examined its potential involvement in this rolling interac- 
tion. bGP has been shown to bind to HA with very high 
affinity (33). A biotinylated from ofbPG was used to deter- 
mine levels of surface HA on SVEC4-10, and these cells do 
bear significant amounts  of HA  on  their  surface  (Fig.  3). 
This  bPG  reactivity is  blocked by soluble HA  and  is  re- 
moved by hyaluronidase treatment of the cells before stain- 
ing.  Significantly,  bPG  incubation  with  SVEC4-10  cells 
1122  CD44-Mediated Rolling on Endothelial Hyaluronate Table 1.  Rolling of Murine Cell Lines in Parallel Plate Flow 
Assays  Correlates with CD44 SuoCace  Expression 
and Fluoresceinated HA Binding 
SVEC  HA 
Cell line  Treatment  CD44"  F1-HA*  ILoll*  Roll* 
BW5147  --  86  69  +  + 
TK23  --  58  148  +  + 
VL3  --  60  84  +  + 
MB23G2  --  90  42  +  + 
MelD54  --  70  65  +  + 
C6VL  --  26  2  -  - 
C6VL  PMA/Io  100  65  +  + 
C6VL  IRAWB  ND  15  -  - 
SAKRTLS12  --  106  4  -  - 
SAKRTLS12  PMA/Io  110  225  +  + 
SAKRTLS  12  IRAWB  ND  10  -  - 
EL4  --  67  6  -  - 
EL4  PMA/Io  112  5  -  - 
EL4  IRAWB  ND  25  -  - 
P,.1.1  --  42  24  -  - 
RI.1  PMA/Io  50  26  -  - 
R1.1  IRAWB  ND  12  --  -- 
EL4  hi  --  4  3  --  -- 
EL4  hi  PMA/Io  27  7  -  - 
*CD44 expression (IM7/GctRIg-PE) and F1-HA  binding are given as 
the mean fluorescence  intensity. 
+, >25 cells/ram  2 per minute; -, <4 cells/mm  2 per minute. Rolling 
was specifically  inhibited by anti-CD44 mAb KM201 (>95%) but not 
significandy  affected by irrelevant control antibody (<14%). 
PMA/Io, PMA plus ionomycin. 
also blocked the rolling BW5147 (Fig. 2 A). The same re- 
agent was used to stain BW5147 cells, and a slight shift in 
fluorescence of less than twofold over background was seen 
(data not shown). However, hyaluronidase treatment of the 
BW5147  cells before  flow assay  had  no  effect  on rolling 
(Fig. 2  A),  again suggesting that it is primarily CD44  ex- 
pressed on BW5147 interacting with hyaluronate expressed 
on the EC that mediates this adhesion. 
To  direcdy address the  role of HA in CD44-mediated 
rolling, BW5147 was infused into the flow chamber over a 
35-ram tissue culture dish that had been coated with 2.5 
mg/ml soluble HA, HS,  or CS-A.  Cells passed across the 
HA-coated dishes  rolled in numbers comparable to  those 
seen on SVEC4-10 plates, whereas control substances did 
not support rolling (Fig. 4). Titration of the HA coating so- 
lution from  10  mg/ml to  as low as 0.1  mg/ml supported 
BW5147 rolling without significant changes in the number 
of cells/ram  2  per  minute  or  rolling velocities  (data  not 
shown).  Treatment of the  HA-coated plates  with  hyalu- 
ronidase but not neuraminidase abrogated the rolling, as did 
pretreatment of plates  with  soluble bPG,  confirming the 
specificity of this cell-ligand interaction (Fig. 4).  The HA 
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rolling interaction could be completely and specifically in- 
hibited by the use of the  HA-blocking anti-CD44 mAbs 
KM201  and KM81  (Fig. 4). IM7 also inhibited the rolling 
interaction,  although  not  completely  (Fig.  4),  consistent 
with previous reports (34). A  control anti-Thyl.  1 antibody 
had no significant effect on rolling. 
In separate  experiments on SVEC4-10 monolayers, ei- 
ther soluble HA or CS-A was added to the BW5147 sus- 
pension at varying concentrations. Introduction of soluble 
HA immediately resulted in inhibition of rolling, with 50% 
inhibition seen at  10  I~g/ml of soluble HA and complete 
inhibition at 250  Ixg/ml (data not shown).  Soluble CS-A 
had no effect on rolling. 
Other Murine Lymphoid and Endothelial Cells  Participate in 
CD44-mediated Rolling.  To determine whether similar roll- 
ing activity is exhibited by other murine cell lines, a panel 
of lymphoid cells was tested for ability to roll on SVEC4-10. 
As  summarized in  Table  1,  the  results  demonstrate  that 
only those cells expressing CD44 display this behavior and 
that the ability to roll on HA-coated plates correlates pre- 
cisely with the ability to roll on SVEC4-10 cells.  Two T 
cell  lines,  TK23  and  VL3,  and  two  B  cell  hybridomas, 
MelD54 and MB23G2, express CD44 and display constitu- 
tive rolling behavior. Thus, a variety ofT and B cell lines ex- 
hibit the rolling interaction. However, CD44 expression alone 
is not sufficient for rolling behavior, since the SAKRTLS12 
and EL4 cell lines express similar high levels of cell surface 
CD44, yet do  not show constitutive rolling behavior (see 
below). 
Two additional EC substrates were also tested for partic- 
ipation in CD44-mediated lymphocyte rolling. TME-3H3, 
an SV40-transformed EC  line (13),  showed staining with 
bPG "~5-10-fold over background (data not shown). These 
cells supported rolling in numbers comparable to that seen 
with SVEC4-10  (40  cells/ram  2 per minute at 2.0  dynes/ 
cm2), and the rolling was completely and specifically abol- 
ished by anti-CD44 mAbs and completely inhibitable with 
0, 
4 
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Figure 3.  bPG binds to hyaluronate on SVEC4-10 cells. SVEC4-10 
cells were incubated  with strepavidin-PE  alone (dotted line) or biotin-con- 
jugated bPG plus strepavidin-PE  (solid  histogram) and analyzed  by FACS  | 
The specificity  ofbGP staining  of SVEC4-10 cells was evaluated  by pre- 
incubating cells with soluble HA (dashed line) or with hyaluronidase  (solid 
line) before staining  with bPG. CS-A 
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Figure  4.  Rolling  of BW5147 cells on  glycosaminoglycan-coated 
dishes in parallel  plate flow assays is mediated by CD44-HA interaction. 
(A) Assay dishes were coated overnight with 2.5 mg/ml CS-A, HS, or 
HA, and BW5147 cells were flowed under conditions of shear stress (2.0 
dynes/cm2). (13) Assay dishes coated with 2.5 mg/ml HA were treated 
with hyaluronidase, neuraminidase,  or bPG before application of lym- 
phoid cells. Both hyaluronidase  and bPG treaanent significandy  inhibited 
rolling, whereas neuraminidase  had no effect. (C) BW5147 cells were in- 
cubated with mAbs to CD44 or Thyl.1 before introduction into the feed 
solution and initiation of flow. All three anti-CD44 antibtdies, but not 
anti-Thyl.1, inhibited BW5147 rolling. 
HA (Fig. 5). Similarly, primary LN endothelial cultures also 
supported  significant levels of rolling, again blockable by 
anti-CD44 mAbs and HA (Fig. 5).  Human umbihcal vein 
EC,  which are  HA-, did not support rolling under these 
conditions. 
CD44-mediated Rolling Can Be Regulated by PMA/Iono- 
mydn, but Not the Activating Antibody IRA WB14.  As  shown 
in Table 1, some of the lymphoid cell lines not showing roll- 
ing activity  (SAKR.TLS12,  EL4)  express  surface  CD44  at 
levels comparable to those that do show this activity. Previ- 
ous findings indicated that among cell lines, F1-HA binding 
does  not always  directly correlate  with  CD44  expression 
(35),  and  phorbol  ester  activation of cell  lines  has  been 
shown to induce soluble and plate-bound HA binding in 
some CD44-expressing cell hnes that do not constitutively 
bind HA (34). Therefore it was of interest to determine the 
influence of such treatment on rolling behavior in these cell 
hnes. After 18 h  of incubation in the presence of PMA plus 
ionomycin, there  was  indeed induction of the  cell  lines 
C6VL  and SAKtLTLS12 to  rolling competency (Table  1 
and Fig. 6). There was also an accompanying significant in- 
crease  in soluble F1-HA binding (Table 1).  Some CD44- 
expressing cell lines, such as EL4 and tL1.1, did not roll in 
response to this activation, nor were these hnes induced to 
bind  significantly increased  amounts  of F1-HA.  Further- 
more, a CD44- cell line, EL4  r~, could not be induced by this 
treatment to  roll  or bind HA,  although slightly increased 
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Figure 5.  Rolling of  BW5147 cells on other EC substrates. TME-3H3 
EC and BALB/c primary  LN EC cultures  were plated in culture dishes as 
described and used in the flow assay. BW5147 cells rolled in significant 
numbers across both kinds of cell monolayer. Rolling on both EC types 
was specifically  inhibited by anti-CD44 antibodies and by soluble HA, 
but not by anti-Thyl. 1. 
levels of CD44 were expressed (Table 1).  It therefore ap- 
pears that there is a direct relationship between HA-bind- 
ing ability and rolling behavior, which is distinct fi:om CD44 
expression alone. 
IRAWB14 is an anti-CD44 antibody that has been re- 
ported to induce F1-HA binding in some CD44-expressing 
cell lines that do not constitutively bind HA (18). Although 
treatment of these cell hnes with antibody did routinely in- 
crease levels of F1-HA binding (Table 1), it is clear that the 
increase  in  F1-HA binding induced was  significantly less 
None 
PMA/Iono 
IRAWB14 
None 
PMA/Iono 
IRAWB1 
0 
H  C6VL 
SAKRTLS12 
....  i  ....  i  ....  t  ....  t 
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Figure 6.  Phorbol  ester activation of routine T cell lines can induce 
rolling on HA-coated dishes. The T cell hnes C6VL and SAKtLTLS12 
were incubated for 18 h with PMA plus ionomycin or for 20 min with 
the  activating anti-CD44 antibody IRAWB14. Cells were introduced 
into the feed solution with or without treatment. Prior incubation of 
lymphoid cells with PMA plus ionomycin, but not with IRAWB14, re- 
suited in the induction of rolling of treated cells on HA plates. 
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of this antibody alone was not suftlcient to cause the cells to 
roll (Fig. 6). Thus, there appears to be a threshold for roll- 
ing behavior that  is higher than  that  required for soluble 
HA binding alone, or the induction for soluble HA binding 
is qualitatively different than that required for roiling. 
Activated Murine Lymphocytes Exhibit CD44-mediated Roil- 
ing.  The phenomenon of CD44-mediated rolling on en- 
dothelium has not been previously described. To establish a 
potential  role  for  CD44-mediated  rolling in  physiologic 
lymphocyte homing,  we next  assessed the  ability of acti- 
vated and nonactivated BALB/c spleen and LN cells to in- 
teract with HA-coated surfaces in the parallel plate flow assay 
(Fig.  7).  Since  CD44  expression  on  normal  lymphocytes 
can be upregulated in vitro by treatment with phorbol ester 
(36), we treated lymphocytes and splenocytes as described 
above for testing on HA-coated surfaces. Activated and non- 
activated cells were stained with F1-HA plus anti-CD44-PE 
at the time  of assay. Consistent with  activation, both  the 
forward and side light scatter profiles of the lymphoid pop- 
ulations were increased (data not shown), indicating a sig- 
nificant blast population (57 vs. 8% of live cells for LN cells 
and 36 vs. 11% for spleen cells). Although significant num- 
bers of BALB/c lymphocytes are CD44 +  without  activa- 
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Figure 7.  CD44-HA--dependent LN and spleen cell rolling after activation in vitro and in vivo. BALB/c LN (A) and spleen cells (B) were stained with 
F1-HA plus IM7/G~RIg~-PE immediately a~er removal from the animals or after 20-h incubation with PMA plus ionomycin. Increased staimng of the 
CD44 + populations with R-HA is seen in the in vitro-activated cell popdations,  (C) Rolling of unactivated and in vitro-activated LN and spleen ceils 
on HA-coated plates. Rollrng was only seen in the activated cell populations and was specifically  irthibited by treatment with ami-CD44 antibody (IMT) 
or with soluble HA, Anti-CD45R  B  had no effect on rolling of activated lymphocytes. (D) Rolling of in vivo--activated  LN cells oil HA- and SVEC4-10- 
coated plates. Rolling was seen orr both substrates  and was inhibited by treatment of cells w~th anti-CD44 antibody. 
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(36, 37), a large CD44+/HA-binding double-positive pop- 
ulation was not found among resting cells, but was present 
after activation of both LN and spleen cells  (Fig. 7, A  and 
B).  Whereas  <1%  of resting LN  cells  and  4% of resting 
splenocytes were  CD44+/HA-binding,  23  and  34%,  re- 
spectively, of the activated cell populations stained for both 
markers. Using the freshly isolated unactivated spleen and 
LN cells, rolling was almost undetectable. In contrast, both 
the activated LN and spleen cells rolled in significant num- 
bers (Fig.  7  C); as many as 28 cells/mm  2 per minute were 
seen  to  roll  in  some  experiments.  Blocking  of activated 
lymphocyte rolling was  equally efficient with  anti-CD44 
(IM7)  or soluble HA, whereas anti-CD45RB, recognizing 
the T-200 antigen generally present on peripheral T  cells, 
had no significant effect (Fig. 7 C). 
Because of the flow dynamics and the limited efficiency 
with which interacting cells  can effectively access  the flat 
plate surface, only a fraction of potentially interacting cells 
passing  through the laminar flow chamber actually have an 
opportunity to  interact with  the  substrate.  Therefore, to 
obtain an estimate of the proportion of cells capable of roll- 
ing in the activated LN population, flow was  interrupted 
and  activated  lymphocytes  were  allowed  to  settle.  We 
found that 26% (+  10.5%)  of the activated LN population 
and 19%  (+  6%) of the activated spleen population rolled 
when flow was reinitiated and that this was CD44 depen- 
dent, consistent with the proportion of cells induced to in- 
creased  CD44-HA  binding  (Fig.  7  A).  As  a  further ap- 
proach  to  determine  the  proportion  of cells  capable  of 
undergoing tethering,  activated LN cells were allowed to 
adhere to HA-coated wells, which were gently rotated un- 
der shear conditions (6). Under these conditions, a similar 
fraction of adherent cells (18  +  4% vs. 2% for unactivated 
cells) was obtained, and this was completely inhibitable by 
anti-CD44  mAbs.  These results  indicate that this CD44- 
HA adhesion event can occur in normal cell populations 
under conditions of cell activation. 
To  further  establish  the  physiologic  relevance  of the 
CD44-mediated interaction, we sought to examine whether 
rolling activity could be  detected in lymphocyte popula- 
tions activated in vivo. Inguinal LN draining a site of com- 
plete adjuvant-induced inflammation at the base of the tail 
were removed 3 d after the last of three weekly challenges. 
FACS  |  analysis showed an increased percentage of CD44- 
HA-binding cells in these nodes (3-6.5%), compared with 
<1%  in  control LN  distal  to  the  injection site from the 
same animals.  When analyzed for CD44-mediated rolling 
on both HA and SVEC4-10, small but significant numbers 
of cells  exhibited rolling behavior (Fig.  7  D).  As with in 
vitro activated lymphocytes, rolling was effectively ablated 
by anti-CD44 mAbs. 
Discussion 
Primary  and  secondary  adhesion  of leukocytes  under 
conditions of physiologic flow have been attributed to se- 
lectins and integrins and their respective ligands  on vascular 
endothelium; other receptors have not been implicated to 
date. In this study, we present in vitro experiments suggest- 
ing  that  another pair  of ligands  can mediate lymphocyte 
rolling on  endothelial monolayers.  In  this  system,  clonal 
lymphoid B  and T  cell lines,  as well as  activated normal 
lymphocytes, roll on LN-derived EC as a result of the in- 
teraction between CD44 and its carbohydrate ligand hyalu- 
ronate.  The  response  of adhesion  to  varying wall  shear 
stress and rolling velocities suggests  that this CD44-medi- 
ated rolling would most likely operate, as  do selectins,  at 
postcapillary venular wall  shear  stresses  (1-4  dynes/cm2), 
but not at arteriolar or arterial stresses (>8 dynes/cm2). Al- 
though  similar  in  character  to  selectin  interactions  with 
their carbohydrate ligands,  our experiments effectively rule 
out a role for the known select-ins and suggest that CD44 
mediates  an  alternative  primary  leukocyte-EC  adhesion 
pathway. 
The association of CD44 with mechanisms of lympho- 
cyte  homing  originated  from  observations  that  antigens 
recognized by  certain  mAbs  against  human  CD44  (38) 
were similar in some properties to gp90  MEL-I4 (39-41), the 
murine LN-specific homing receptor L-selectin. Some of 
these anti-CD44 antibodies were also reported to interfere 
with  binding  of  lymphocytes  to  the  high  endothelial 
venules of secondary lymphoid tissues  in frozen sections. 
Since the homologue of L-selectin exists  in humans,  with 
similar distribution and function to that described in mice 
(42-44),  the role that CD44  plays  in normal lymphocyte 
trafficking to secondary lymphoid tissues has remained un- 
resolved. Nonetheless, it has been shown that interactions 
of CD44  with  its  major ligand  hyaluronate  can  mediate 
static binding of lymphocytes to cultured EC lines in both 
mice and humans (15,  16, 18). The physiologic function of 
this interaction has not been defined. Our findings indicat- 
ing  a  role  for  CD44  in  primary  adhesion  under  flow 
strengthens the possibility that this molecule participates in 
determining  patterns  of lymphocyte traffic.  However,  as 
we discuss below, we consider the evidence as favoring the 
likelihood that  this  interaction primarily manifests at  ter- 
tiary extralymphoid sites  of inflammation rather than sec- 
ondary lymphoid tissues. 
CD44 constitutes a widely distributed set of cell surface 
glycoproteins that has  been studied in numerous systems, 
with the described roles for CD44 ranging from extracellu- 
lar matrix binding, lymphocyte homing, and activation, to 
lymphopoiesis and metastasis  (for review see reference 45). 
CD44 has been identified on most hematopoietic cells  as 
well as nonhematolymphoid elements and, biochemically, 
has  been shown  to  display great molecular heterogeneity 
owing both to variegated posttranslational modification and 
alternative exon use. Primary molecular analysis predicted a 
protein bearing homology to proteoglycan core and carti- 
lage  link proteins, which  are known  to interact with the 
glycosaminoglycan hyaluronate, a major component of the 
extracellular matrix.  Although  CD44  has  been shown  to 
bind other ligands,  it is well established that HA is indeed a 
major  ligand  for  CD44.  The  physiological  role  of the 
CD44-HA interaction has not yet been clarified. 
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EC in the described rolling interaction is also hyaluronate 
(Figs. 3 and 4). In addition, the major properties of the roll- 
ing interaction can be duplicated on HA-coated plates (Fig. 
4),  and there is a direct relationship for all cells  tested be- 
tween endothehal and HA plate rolling (Table 1). Average 
rolling velocities on HA-coated plates  (13.0  +  3.5  p,m/s) 
over a  broad  range  of HA  concentrations  are  similar  to 
those found on EC, suggesting that the ligand that is bruit- 
ing in  this behavior is the  amount and/or activity of cell 
surface CD44  capable of binding HA rather than the HA 
disaccharide polymer.  Thus,  the  observed rolling interac- 
tion is not effectively different on various endothelial mono- 
layers and over a wide range of concentrations of HA plates, 
likely overlapping what is relevant in vivo. These observa- 
tions add to the selectins and their carbohydrate ligands an- 
other receptor--carbohydrate pair, CD44 and HA, capable of 
mediating primary adhesion and rolling under shear forces. 
HA binding  is  not  generally a  constitutive  property of 
CD44; rather there appears to be activation dependence of 
CD44 for this characteristic to manifest (34).  The mecha- 
nism by which CD44 becomes "activated" to bind HA is 
not known,  although structural and posttranslational alter- 
ations of CD44 abound, and their relationship to HA bind- 
ing is controversial (45,  46).  We tested several cell lines of 
both B  and T  lineage and demonstrated constitutive high- 
level HA binding as well as rolling (Table  1).  In addition, 
we show that other lymphoid hnes as well as normal lym- 
phocytes can be "activated" to CD44-mediated rolling.  In 
our experiments,  PMA and ionomycin treatment of both 
SAKRTLS12 and C6VL caused increases in F1-HA binding 
and resulted in conversion to a rolling phenotype. The in- 
creased  F1-HA-binding levels on  SAKRTLS12  (Table  1) 
did not lead to comparable elevated levels of rolling (Fig. 
6).  This may indicate that CD44 density is also an impor- 
tant factor in determining interactions under shear force, or 
may simple reflect that the CD44-HA interaction has dif- 
ferent features  in  static  assays  on  immobilized HA versus 
binding to soluble HA (45).  Alternatively, it is possible that 
the cell surface distribution of CD44 is different on differ- 
ent cell lines; for example, perhaps CD44 on C6VL is more 
accessibly  distributed  or  clustered  on  microvilli  than  on 
SAKR.  Consistent with previous  reports showing nonin- 
ducibility  to  HA  binding  of some  CD44-expressing  cell 
hnes  (35),  some of our CD44 + cells  also  could not be in- 
duced to roll (Table 1). 
It has been  demonstrated  that  resting normal T  and B 
cells,  indeed  all  normal  hematopoetic  cells  that  express 
CD44,  do not appreciably bind HA in vitro (45).  Normal 
T  cells, but not bone marrow myeloid cells, can be induced 
to bind  HA with  the  antibody IRAWB14  (18,  36)  or in 
vivo in an allogeneic response (47).  Resting B  cells can be 
induced to bind HA after several days culture in IL-5 (48) 
or in vivo in a chronic graft vs. host reaction (49).  Our re- 
sults  indicate  that CD44  and HA binding can be induced 
on T  cells from spleen and LN in vitro by PMA/ionomy- 
cin  (but not PMA alone  [18,  36]),  and that this treatment 
results in a population that also exhibits CD44--HA-medi- 
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ated rolling on EC (Fig. 7 C). We also obtained results dem- 
onstrating  the  in  vivo  relevance  of increased  CD44-HA 
binding and subsequent rolling during the course of an im- 
mune response in the LN draining a site of local inflamma- 
tion (Fig. 7 D). Similar results have also been obtained with 
spleen cells  taken from animals undergoing acute GVHD, 
wherein  T  cells  have been stimulated across an allogeneic 
barrier (DeGrendele, H.C., unpubhshed results). These ex- 
periments emphasize that cells with this interactive poten- 
tial  clearly are produced  in  the  course  of an immune re- 
sponse, supporting an in vivo role. 
Our inability to separate HA binding from rolling (Table 
1) by any means is highly suggestive that they both are the 
result of the CD44-HA interaction.  Quantitatively,  how- 
ever, it seems clear that the threshold for detection of solu- 
ble HA binding is considerably lower than that for the roll- 
ing  interaction.  This  is  illustrated  by  use  of IRAWB14, 
which, consistent with previous reports (18, 36), resulted in 
three  of four cell lines  in  rapid  2.5-7-fold  increases  over 
baseline levels of soluble HA binding; yet in none of these 
were the increases suflacient for HA-mediated rolling (Ta- 
ble  1).  It is  likely that  this  reflects a  requirement  for in- 
creased  numbers  of CD44-HA  interactions  to  overcome 
the  fluid  shear  stress  forces  of physiologic  flow.  Alterna- 
tively,  the  difference between  IRAWB  and  PMA induc- 
tion may be the result of redistribution  of CD44 to more 
surface-accessible compartments of the  plasma membrane 
such as microvilli; other potential mechanisms such as phos- 
phorylation events, posttranslational glycosylation, exon us- 
age, or CD44 clustering could also be involved. Although 
the mechanism remains to be clarified, the observation that 
CD44 activation can lead to primary adhesion under physi- 
ologic flow now suggests one possible role for this induction. 
It has long been appreciated that memory/effector and 
lymphoblast populations  engage  in  discrete  tissue-specific 
homing pathways. In particular, recirculation of these sub- 
sets tends to primarily involve extralymphoid (tertiary) tis- 
sues,  that is, those inflammatory sites at which final effector 
cells  exert their function.  Such preferred homing mecha- 
nisms of memory/effector subsets have been described for 
inflamed skin, intestinal lamina propria, and inflamed syn- 
ovium  (for review see reference  50).  There is  also  ample 
evidence  for increased  CD44  expression  in  activated and 
memory/effector lymphocyte populations (51,  52). There- 
fore, we would envisage that antigen-specific or other acti- 
vation signals  would  be accompanied by increased  CD44 
expression and "activation" to HA-binding proficiency. Such 
activated cells could then be released into the circulation to 
sites of antigen localization in tertiary sites,  where HA on 
endothelium would serve as hgand to initiate adhesion and 
support  extravasation  of activated  memory/effector lym- 
phocyte subsets. In support of this notion, anti-CD44 mAb 
treatment  of mice prevented lymphocyte extravasation at 
an inflammatory site  of delayed-type hypersensitivity, but 
had  no  influence  on  normal  recirculation  (53).  We  have 
also  observed CD44-mediated  rolling  on  HA by both in 
vitro- and in vivo-activated (but not resting) human lym- 
phocytes (DeGrendele, H.C., unpubhshed data). Consider- ing  the  very  wide  distribution  of both  CD44  and  HA 
throughout the organism, the need for stringent regulation 
of CD44-HA  binding might well be anticipated.  ILegula- 
tion of HA on endothelium in response to local pathophys- 
iologic conditions would be one potential control point.  In 
this  regard,  hyaluronate  is  found  in  both  small  and  large 
vessels (33, 54) and has also been shown on lumenal aspects 
within  venules of LN  (15).  We  have confirmed the  pres- 
ence of HA on the lumenal aspect of small vessels in frozen 
sections of LN as well as spleen using the bPG reagent (data 
not shown). In addition,  HA deposition has been shown to 
be  markedly  enriched  intradermally  in  the  course  of de- 
layed type hypersensitivity  reactions  (55),  perhaps provid- 
ing more  efficient  CD44-mediated  interaction.  Thus,  we 
propose that the CD44-HA interaction would serve as part 
of a mechanism for regulating trafficking of activated effec- 
tor cells to inflammatory sites,  and potentially the dissemina- 
tion ofCD44 + metastatic cells to endothelium at target sites. 
The paradigm  of the  pathway of leukocyte adhesion  to 
endothelium as a multistep cascade determined by a variety of 
adhesion  receptors  continues  to  serve  as  a  useful  model, 
and it has evolved and continues to be refined to accomo- 
date new observations. The findings presented here add new 
complexities that broaden  the  concept in significant ways. 
We show that primary adhesion is not the exclusive prov- 
ince  of selectins  or integnns,  but  also of activated  CD44, 
thereby  providing  a  potential  physiologic  role  for  the 
CD44-HA interaction.  The ability to rapidly alter binding 
affinities to affect functional leukocyte-EC intexaction  has 
been described for integrins  (56,  57) and may indeed be a 
common property of many leukocyte adhesion  molecules. 
Thus, CD44 can now be added to a growing list of adhesion 
receptors sharing a  constellation  of features,  However, the 
CD44  activation,  which  transpires  over  hours,  is  distinct 
from that ofintegrin receptors, which requires minutes. The 
slower  induction  and  relatively  prolonged  duration  of 
CD44 activation is more in keeping with  a role in mem- 
ory/effector  cell  homing  outlined  above.  The  adhesive 
behavior  described  in  this  system  may  suggest  that  such 
primary rolling is also a common property of receptor-car- 
bohydrate  figand  interactions  under flow.  These  observa- 
tions add to the repertoire of elements that can regulate ad- 
hesion  under  flow  and  emphasize  the  diverse  array  of 
leukocyte adhesion receptors and their vascular ligands that 
can participate in the control of leukocyte traffic. 
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